Open main menu

Pages with the most revisions

Showing below up to 500 results in range #251 to #750.

View (previous 500 | next 500) (20 | 50 | 100 | 250 | 500)

  1. Protective action guide‏‎ (2 revisions)
  2. Radiation worker‏‎ (2 revisions)
  3. Decay constant‏‎ (2 revisions)
  4. Self-help protection‏‎ (2 revisions)
  5. Individual-related‏‎ (2 revisions)
  6. Dose of record Hp (10)‏‎ (2 revisions)
  7. Electrophysiology‏‎ (2 revisions)
  8. Storage‏‎ (2 revisions)
  9. Track structure‏‎ (2 revisions)
  10. Mendelian diseases‏‎ (2 revisions)
  11. Accreditation‏‎ (2 revisions)
  12. Neurological syndrome‏‎ (2 revisions)
  13. Genomic integrity‏‎ (2 revisions)
  14. Occupational exposure‏‎ (2 revisions)
  15. Hazard‏‎ (2 revisions)
  16. Peak skin dose‏‎ (2 revisions)
  17. Bragg peak‏‎ (2 revisions)
  18. Radioactive dispersion device‏‎ (2 revisions)
  19. Radon: Units of Measure‏‎ (2 revisions)
  20. Coronary heart disease‏‎ (2 revisions)
  21. Reference air kerma‏‎ (2 revisions)
  22. Decommissioning‏‎ (2 revisions)
  23. ICRP Task Groups on Radiological Protection in Healthcare‏‎ (2 revisions)
  24. Dose-threshold‏‎ (2 revisions)
  25. Individual decontamination‏‎ (2 revisions)
  26. Subcutaneous tissue‏‎ (2 revisions)
  27. Low dose rate‏‎ (2 revisions)
  28. Transfer compartment‏‎ (2 revisions)
  29. Mitigation‏‎ (2 revisions)
  30. Fractional absorption in the gastrointestinal tract‏‎ (2 revisions)
  31. Action Level‏‎ (2 revisions)
  32. Upper reference levels‏‎ (2 revisions)
  33. Neurovascular syndrome‏‎ (2 revisions)
  34. Health Surveillance‏‎ (2 revisions)
  35. Pelagic‏‎ (2 revisions)
  36. Basal cell‏‎ (2 revisions)
  37. Practical radiological protection culture‏‎ (2 revisions)
  38. Branching fraction‏‎ (2 revisions)
  39. Chronic exposure‏‎ (2 revisions)
  40. Radioactive source‏‎ (2 revisions)
  41. Colony‏‎ (2 revisions)
  42. Cosmic Radiation in Aviation‏‎ (2 revisions)
  43. Decontamination‏‎ (2 revisions)
  44. Relocation‏‎ (2 revisions)
  45. Diastasis‏‎ (2 revisions)
  46. Risk coefficient‏‎ (2 revisions)
  47. Individual monitoring‏‎ (2 revisions)
  48. Dose per unit intake coefficient‏‎ (2 revisions)
  49. Source term‏‎ (2 revisions)
  50. Emergency‏‎ (2 revisions)
  51. Latent time/period or latency interval‏‎ (2 revisions)
  52. Low level waste‏‎ (2 revisions)
  53. Exposure, external or internal‏‎ (2 revisions)
  54. Graft vs host disease‏‎ (2 revisions)
  55. Air-kerma, incident‏‎ (2 revisions)
  56. Heliosphere‏‎ (2 revisions)
  57. Qualified expert‏‎ (2 revisions)
  58. Class SR-0 gases‏‎ (2 revisions)
  59. Radioactive substance‏‎ (2 revisions)
  60. Reference biokinetic model‏‎ (2 revisions)
  61. Decontamination factor‏‎ (2 revisions)
  62. Remedial action‏‎ (2 revisions)
  63. ICRPædia Guide to Dose Coefficients‏‎ (2 revisions)
  64. Dose rate‏‎ (2 revisions)
  65. Intervention Level‏‎ (2 revisions)
  66. Emergency exposure situation‏‎ (2 revisions)
  67. Substantial radiation dose level‏‎ (2 revisions)
  68. Erythropoietin‏‎ (2 revisions)
  69. Exposure (in the context of inhalation)‏‎ (2 revisions)
  70. Transfer rate‏‎ (2 revisions)
  71. Multi-detector computed tomography‏‎ (2 revisions)
  72. Fractionation and dose delivery patterns‏‎ (2 revisions)
  73. Percutaneous coronary intervention‏‎ (2 revisions)
  74. Prevailing circumstances‏‎ (2 revisions)
  75. Broad beam therapy irradiation technique‏‎ (2 revisions)
  76. Class SR-1 gases‏‎ (2 revisions)
  77. Committed effective dose‏‎ (2 revisions)
  78. Radon Recommendations for Authorities‏‎ (2 revisions)
  79. Cost-benefit analysis‏‎ (2 revisions)
  80. Reference individual‏‎ (2 revisions)
  81. Remediation‏‎ (2 revisions)
  82. Dichotomous‏‎ (2 revisions)
  83. Risk of Exposure to Radon‏‎ (2 revisions)
  84. Dose rate effectiveness factor‏‎ (2 revisions)
  85. South Atlantic anomaly‏‎ (2 revisions)
  86. Interventional procedure‏‎ (2 revisions)
  87. Emergency plan‏‎ (2 revisions)
  88. Ethics‏‎ (2 revisions)
  89. Lymphatic system‏‎ (2 revisions)
  90. ALARA‏‎ (2 revisions)
  91. Transforming growth factor‏‎ (2 revisions)
  92. Hierarchical tissues‏‎ (2 revisions)
  93. Area monitoring‏‎ (2 revisions)
  94. Pericarditis‏‎ (2 revisions)
  95. Benthic‏‎ (2 revisions)
  96. Principle of application of dose limits‏‎ (2 revisions)
  97. Bronchial region‏‎ (2 revisions)
  98. Class SR-2 gases‏‎ (2 revisions)
  99. Radioactivity‏‎ (2 revisions)
  100. Committed equivalent dose‏‎ (2 revisions)
  101. Radon Recommendations for Workplaces‏‎ (2 revisions)
  102. Reference level‏‎ (2 revisions)
  103. Deontological Ethics‏‎ (2 revisions)
  104. Repopulation‏‎ (2 revisions)
  105. Differentiation‏‎ (2 revisions)
  106. Routine monitoring‏‎ (2 revisions)
  107. ICRPædia Guide to Radon‏‎ (2 revisions)
  108. Special (non-routine) monitoring‏‎ (2 revisions)
  109. Lifetime risk‏‎ (2 revisions)
  110. Macrophage colony stimulating factor‏‎ (2 revisions)
  111. Multiplicative risk projection model‏‎ (2 revisions)
  112. Activity‏‎ (2 revisions)
  113. High level waste‏‎ (2 revisions)
  114. Clearance‏‎ (2 revisions)
  115. Representative organism (non-human biota)‏‎ (2 revisions)
  116. ICRPædia Guide to the Basics of Ionising Radiation‏‎ (2 revisions)
  117. Dose constraint‏‎ (2 revisions)
  118. Early normal tissue responses‏‎ (2 revisions)
  119. Threshold dose for tissue reactions‏‎ (2 revisions)
  120. Magnetosphere‏‎ (2 revisions)
  121. Beta-minus decay‏‎ (2 revisions)
  122. Clearance level‏‎ (2 revisions)
  123. Radiographer‏‎ (2 revisions)
  124. Representative person‏‎ (2 revisions)
  125. Safety‏‎ (2 revisions)
  126. Dose conversion coefficient‏‎ (2 revisions)
  127. Edema‏‎ (2 revisions)
  128. Specific effective energy‏‎ (2 revisions)
  129. Limitation of dose‏‎ (2 revisions)
  130. Excess relative risk‏‎ (2 revisions)
  131. Exposure situation‏‎ (2 revisions)
  132. Transmission detection system‏‎ (2 revisions)
  133. Multistage tumorigenesis‏‎ (2 revisions)
  134. Non-sphericity parameter‏‎ (2 revisions)
  135. Growth factor‏‎ (2 revisions)
  136. Alimentary tract transfer factor‏‎ (2 revisions)
  137. Pharynx‏‎ (2 revisions)
  138. Beta-plus decay‏‎ (2 revisions)
  139. Calculating Doses from Intakes of Radionuclides‏‎ (2 revisions)
  140. Cumulative dose‏‎ (2 revisions)
  141. Reproductive integrity‏‎ (2 revisions)
  142. Safety case‏‎ (2 revisions)
  143. Slow repair‏‎ (2 revisions)
  144. Effect Dose 50‏‎ (2 revisions)
  145. Isotropic geometry‏‎ (2 revisions)
  146. Endogeneous excretion‏‎ (2 revisions)
  147. Lineal energy‏‎ (2 revisions)
  148. Thyroid blocking‏‎ (2 revisions)
  149. Exposure to Radon at Home‏‎ (2 revisions)
  150. Transparency‏‎ (2 revisions)
  151. GATA binding protein 2‏‎ (2 revisions)
  152. Waste disposal‏‎ (2 revisions)
  153. Non-targeted effects‏‎ (2 revisions)
  154. Hormones‏‎ (2 revisions)
  155. Authorization‏‎ (2 revisions)
  156. Procedural values‏‎ (2 revisions)
  157. Clonogenic cells‏‎ (2 revisions)
  158. Curie‏‎ (2 revisions)
  159. Residual dose‏‎ (2 revisions)
  160. Safety culture‏‎ (2 revisions)
  161. Solar cosmic radiation‏‎ (2 revisions)
  162. Inhalability‏‎ (2 revisions)
  163. Spontaneous fission‏‎ (2 revisions)
  164. Itinerant (radiation) worker‏‎ (2 revisions)
  165. Linear-non-threshold model‏‎ (2 revisions)
  166. Trapped particles‏‎ (2 revisions)
  167. Acute radiation syndrome‏‎ (2 revisions)
  168. Orphan source‏‎ (2 revisions)
  169. Hounsfield unit‏‎ (2 revisions)
  170. Authorized limit‏‎ (2 revisions)
  171. Planned exposure situation‏‎ (2 revisions)
  172. Progenitor cell‏‎ (2 revisions)
  173. Cardiac arrhythmias‏‎ (2 revisions)
  174. Radiation belt‏‎ (2 revisions - redirect page)
  175. Clonogenic survival‏‎ (2 revisions)
  176. Reasonableness‏‎ (2 revisions)
  177. Cytokines‏‎ (2 revisions)
  178. Respiratory protection‏‎ (2 revisions)
  179. Disposal‏‎ (2 revisions)
  180. Scintigraphy‏‎ (2 revisions)
  181. Dose criteria‏‎ (2 revisions)
  182. Solar cycle‏‎ (2 revisions)
  183. Inner bremsstrahlung‏‎ (2 revisions)
  184. Environmental exposure‏‎ (2 revisions)
  185. Systemic model‏‎ (2 revisions)
  186. Linear-quadratic dose response model‏‎ (2 revisions)
  187. Exempt waste‏‎ (2 revisions)
  188. Time factor‏‎ (2 revisions)
  189. Myocardial perfusion‏‎ (2 revisions)
  190. Adaptive response‏‎ (2 revisions)
  191. What is Radon?‏‎ (2 revisions)
  192. Alveolar-interstitial region‏‎ (2 revisions)
  193. Autoimmune disease‏‎ (2 revisions)
  194. Platelet-derived growth factor‏‎ (2 revisions)
  195. ICRP Publication 118‏‎ (2 revisions)
  196. Cardiac valve diseases‏‎ (2 revisions)
  197. Radiation modifier‏‎ (2 revisions)
  198. Radiological protection principles‏‎ (2 revisions)
  199. Regional diagnostic reference levels‏‎ (1 revision)
  200. ICRP Publication 30 (Supplement B to Part 3)‏‎ (1 revision)
  201. Derived reference level‏‎ (1 revision)
  202. ICRP Publication 95‏‎ (1 revision)
  203. ICRP Publication 43‏‎ (1 revision)
  204. Disposal facility‏‎ (1 revision)
  205. Sealed source‏‎ (1 revision)
  206. ICRP Publication 58‏‎ (1 revision)
  207. Solar flare‏‎ (1 revision)
  208. ICRP Publication 72‏‎ (1 revision)
  209. ICRP Publication 87‏‎ (1 revision)
  210. Linear dose response‏‎ (1 revision)
  211. Mean glandular dose‏‎ (1 revision)
  212. Absorption Type‏‎ (1 revision - redirect page)
  213. Trophic level‏‎ (1 revision)
  214. Additional dose‏‎ (1 revision)
  215. Nuclear medicine‏‎ (1 revision)
  216. Ambient dose equivalent‏‎ (1 revision)
  217. Human Respiratory Tract Model‏‎ (1 revision)
  218. Automatic exposure control‏‎ (1 revision)
  219. Pooled analysis‏‎ (1 revision)
  220. ICRP Publication 105‏‎ (1 revision)
  221. ICRP Publication 119‏‎ (1 revision)
  222. Radiation risk‏‎ (1 revision)
  223. ICRP Publication 133‏‎ (1 revision)
  224. ICRP Publication 148‏‎ (1 revision)
  225. ICRP Publication 22‏‎ (1 revision)
  226. Registry‏‎ (1 revision)
  227. ICRP Publication 30 (Supplement to Part 1)‏‎ (1 revision)
  228. Designated area‏‎ (1 revision)
  229. ICRP Publication 96‏‎ (1 revision)
  230. ICRP Publication 44‏‎ (1 revision)
  231. Distribution coefficient‏‎ (1 revision)
  232. Secondary radiation‏‎ (1 revision)
  233. ICRP Publication 59‏‎ (1 revision)
  234. Intake‏‎ (1 revision)
  235. ICRP Publication 73‏‎ (1 revision)
  236. Standard-size adult‏‎ (1 revision)
  237. ICRP Publication 88‏‎ (1 revision)
  238. Epigenetic effects‏‎ (1 revision)
  239. 1928 Recommendations‏‎ (1 revision)
  240. Tissue reaction‏‎ (1 revision)
  241. Measured quantity‏‎ (1 revision)
  242. Tumour suppressor gene‏‎ (1 revision)
  243. National DRL‏‎ (1 revision)
  244. Additive risk projection model‏‎ (1 revision)
  245. Oxygen enhancement ratio‏‎ (1 revision)
  246. Population risk‏‎ (1 revision)
  247. ICRP Publication 106‏‎ (1 revision)
  248. ICRP Publication 12‏‎ (1 revision)
  249. ICRP Publication 134‏‎ (1 revision)
  250. Cobblestone area forming cell assay‏‎ (1 revision)
  251. ICRP Publication 149‏‎ (1 revision)
  252. ICRP Publication 23‏‎ (1 revision)
  253. DRL quantity‏‎ (1 revision)
  254. ICRP Publication 30 (Supplement to Part 2)‏‎ (1 revision)
  255. Detector quantum efficiency‏‎ (1 revision)
  256. ICRP Publication 97‏‎ (1 revision)
  257. ICRP Publication 45‏‎ (1 revision)
  258. Secretory cells‏‎ (1 revision)
  259. ICRP Publication 6‏‎ (1 revision)
  260. Intensity-modulated radiotherapy‏‎ (1 revision)
  261. ICRP Publication 74‏‎ (1 revision)
  262. Stem cell‏‎ (1 revision)
  263. Kerma approximation‏‎ (1 revision)
  264. ICRP Publication 89‏‎ (1 revision)
  265. Exogenous excretion‏‎ (1 revision)
  266. 1931 Recommendations‏‎ (1 revision)
  267. National radon survey‏‎ (1 revision)
  268. Adenoma‏‎ (1 revision)
  269. Potential alpha energy concentration‏‎ (1 revision)
  270. ICRP Publication 107‏‎ (1 revision)
  271. ICRP Publication 120‏‎ (1 revision)
  272. Carers and comforters‏‎ (1 revision)
  273. ICRP Publication 135‏‎ (1 revision)
  274. ICRP Publication 15‏‎ (1 revision)
  275. Redox‏‎ (1 revision)
  276. ICRP Publication 24‏‎ (1 revision)
  277. Relative biological effectiveness‏‎ (1 revision)
  278. ICRP Publication 31‏‎ (1 revision)
  279. Deterministic effect‏‎ (1 revision)
  280. ICRP Publication 98‏‎ (1 revision)
  281. ICRP Publication 46‏‎ (1 revision)
  282. ICRP Publication 60‏‎ (1 revision)
  283. Dose modifying factor‏‎ (1 revision)
  284. Somatic effect‏‎ (1 revision)
  285. ICRP Publication 75‏‎ (1 revision)
  286. ICRP Publication 9‏‎ (1 revision)
  287. Targeted effects‏‎ (1 revision)
  288. 1934 Recommendations‏‎ (1 revision)
  289. Access control‏‎ (1 revision)
  290. Typical value‏‎ (1 revision)
  291. General Information: Radon‏‎ (1 revision - redirect page)
  292. Particle transport‏‎ (1 revision)
  293. ICRP Publication 108‏‎ (1 revision)
  294. Brachytherapy‏‎ (1 revision)
  295. ICRP Publication 121‏‎ (1 revision)
  296. Case–control study‏‎ (1 revision)
  297. ICRP Publication 136‏‎ (1 revision)
  298. Collective dose‏‎ (1 revision)
  299. ICRP Publication 150‏‎ (1 revision)
  300. ICRP Publication 25‏‎ (1 revision)
  301. ICRP Publication 26‏‎ (1 revision)
  302. DS86‏‎ (1 revision)
  303. Relative life lost‏‎ (1 revision)
  304. ICRP Publication 32‏‎ (1 revision)
  305. ICRP Publication 99‏‎ (1 revision)
  306. ICRP Publication 47‏‎ (1 revision)
  307. Security screening‏‎ (1 revision)
  308. ICRP Publication 61‏‎ (1 revision)
  309. ICRP Publication 76‏‎ (1 revision)
  310. Stochastic effect‏‎ (1 revision)
  311. Equilibrium equivalent concentration‏‎ (1 revision)
  312. Expanded radiation field‏‎ (1 revision)
  313. 1937 Recommendations‏‎ (1 revision)
  314. Tolerance dose‏‎ (1 revision)
  315. Adventitious source‏‎ (1 revision)
  316. Occupancy factor‏‎ (1 revision)
  317. Annual intake‏‎ (1 revision)
  318. ICRP Publication 109‏‎ (1 revision)
  319. ICRP Publication 122‏‎ (1 revision)
  320. ICRP Publication 137‏‎ (1 revision)
  321. Radon-prone area‏‎ (1 revision)
  322. ICRP Publication 151‏‎ (1 revision)
  323. Reference Person‏‎ (1 revision)
  324. ICRP Publication 27‏‎ (1 revision)
  325. Relative risk‏‎ (1 revision)
  326. ICRP Publication 33‏‎ (1 revision)
  327. Detriment-adjusted risk‏‎ (1 revision)
  328. Ring chromosome‏‎ (1 revision)
  329. ICRP Supporting Guidance 2‏‎ (1 revision)
  330. ICRP Publication 48‏‎ (1 revision)
  331. Dose-response function‏‎ (1 revision)
  332. ICRP Publication 62‏‎ (1 revision)
  333. International Commission on Radiological Protection‏‎ (1 revision)
  334. ICRP Publication 77‏‎ (1 revision)
  335. Lag‏‎ (1 revision)
  336. Equilibrium factor‏‎ (1 revision)
  337. Teratocarcinoma‏‎ (1 revision)
  338. Low dose‏‎ (1 revision)
  339. 1950 Recommendations‏‎ (1 revision)
  340. Backscatter factor‏‎ (1 revision)
  341. Potentially lethal damage repair‏‎ (1 revision)
  342. ICRP Publication 10A‏‎ (1 revision)
  343. ICRP Publication 123‏‎ (1 revision)
  344. Charged-particle equilibrium‏‎ (1 revision)
  345. ICRP Publication 138‏‎ (1 revision)
  346. Collimation‏‎ (1 revision)
  347. ICRP Publication 152‏‎ (1 revision)
  348. ICRP Publication 28‏‎ (1 revision)
  349. Relative survival‏‎ (1 revision)
  350. ICRP Publication 34‏‎ (1 revision)
  351. ICRP Publication 49‏‎ (1 revision)
  352. ICRP Publication 63‏‎ (1 revision)
  353. Source region‏‎ (1 revision)
  354. ICRP Publication 78‏‎ (1 revision)
  355. Elemental dose‏‎ (1 revision)
  356. Late normal tissue responses‏‎ (1 revision)
  357. Exposed individuals‏‎ (1 revision)
  358. 1954 Recommendations‏‎ (1 revision)
  359. Α/β value‏‎ (1 revision)
  360. Oncogene‏‎ (1 revision)
  361. Apoptosis‏‎ (1 revision)
  362. ICRP Publication 11‏‎ (1 revision)
  363. ICRP Publication 124‏‎ (1 revision)
  364. ICRP Publication 139‏‎ (1 revision)
  365. ICRP Publication 153‏‎ (1 revision)
  366. ICRP Publication 29‏‎ (1 revision)
  367. ICRP Publication 35‏‎ (1 revision)
  368. ICRP Publication 5‏‎ (1 revision)
  369. Dose-threshold hypothesis‏‎ (1 revision)
  370. Severe deterministic injury‏‎ (1 revision)
  371. ICRP Publication 64‏‎ (1 revision)
  372. Intervention‏‎ (1 revision)
  373. ICRP Publication 79‏‎ (1 revision)
  374. Sublethal damage repair‏‎ (1 revision)
  375. 1956 Recommendations‏‎ (1 revision)
  376. Transfer of risk‏‎ (1 revision)
  377. Molecular imaging‏‎ (1 revision)
  378. Activation‏‎ (1 revision)
  379. Noise‏‎ (1 revision)
  380. ΓH2AX foci‏‎ (1 revision)
  381. Operating management‏‎ (1 revision)
  382. Pencil beam‏‎ (1 revision)
  383. ICRP Publication 1‏‎ (1 revision)
  384. Baseline disease rates‏‎ (1 revision)
  385. Practice‏‎ (1 revision)
  386. ICRP Publication 110‏‎ (1 revision)
  387. Breakpoint cluster region/abelson‏‎ (1 revision)
  388. ICRP Publication 125‏‎ (1 revision)
  389. ICRP Publication 14‏‎ (1 revision)
  390. Commissioning‏‎ (1 revision)
  391. ICRP Publication 154‏‎ (1 revision)
  392. Cosmic radiation‏‎ (1 revision)
  393. ICRP Publication 3‏‎ (1 revision)
  394. ICRP Publication 36‏‎ (1 revision)
  395. Dicentric chromosome‏‎ (1 revision)
  396. Risk model‏‎ (1 revision)
  397. ICRP Publication 50‏‎ (1 revision)
  398. Dose and dose-rate effectiveness factor‏‎ (1 revision)
  399. Sheltering‏‎ (1 revision)
  400. Induced genomic instability‏‎ (1 revision)
  401. ICRP Publication 65‏‎ (1 revision)
  402. ICRP Publication 8‏‎ (1 revision)
  403. Licensee‏‎ (1 revision)
  404. Thermodynamic diameter‏‎ (1 revision)
  405. Low linear energy transfer radiation‏‎ (1 revision)
  406. 1959 Decisions‏‎ (1 revision)
  407. Nominal risk coefficient‏‎ (1 revision)
  408. Hereditary effect‏‎ (1 revision)
  409. ICRP Publication 10‏‎ (1 revision)
  410. ICRP Publication 111‏‎ (1 revision)
  411. Quality control testing‏‎ (1 revision)
  412. ICRP Publication 126‏‎ (1 revision)
  413. Radioactive waste‏‎ (1 revision)
  414. ICRP Publication 140‏‎ (1 revision)
  415. ICRP Publication 155‏‎ (1 revision)
  416. ICRP Publication 30‏‎ (1 revision)
  417. Dental and maxillofacial imaging‏‎ (1 revision)
  418. ICRP Publication 37‏‎ (1 revision)
  419. ICRPædia Guide to Radiological Protection in Healthcare‏‎ (1 revision - redirect page)
  420. ICRP Publication 51‏‎ (1 revision)
  421. Shielding‏‎ (1 revision)
  422. ICRP Publication 66‏‎ (1 revision)
  423. ICRP Publication 80‏‎ (1 revision)
  424. Superposition principle‏‎ (1 revision)
  425. Life Span Study‏‎ (1 revision)
  426. Thoracic airways‏‎ (1 revision)
  427. Multifactorial diseases‏‎ (1 revision)
  428. Active detection system‏‎ (1 revision)
  429. Nominal value‏‎ (1 revision)
  430. ICRP Publication 100‏‎ (1 revision)
  431. ICRP Publication 112‏‎ (1 revision)
  432. ICRP Publication 127‏‎ (1 revision)
  433. ICRP Publication 141‏‎ (1 revision)
  434. ICRP Publication 16‏‎ (1 revision)
  435. ICRP Publication 30 (Index)‏‎ (1 revision)
  436. ICRP Publication 38‏‎ (1 revision)
  437. ICRP Publication 52‏‎ (1 revision)
  438. Dose commitment‏‎ (1 revision)
  439. ICRP Publication 67‏‎ (1 revision)
  440. Doubling dose‏‎ (1 revision)
  441. ICRP Publication 81‏‎ (1 revision)
  442. Supervised area‏‎ (1 revision)
  443. Evacuation‏‎ (1 revision)
  444. Thoron progeny‏‎ (1 revision)
  445. Exposure index‏‎ (1 revision)
  446. AML/eto‏‎ (1 revision)
  447. Transgenerational effect‏‎ (1 revision)
  448. Frequent flyer‏‎ (1 revision)
  449. Non-homologous end joining‏‎ (1 revision)
  450. Optimisation of protection‏‎ (1 revision)
  451. Attributable risk‏‎ (1 revision)
  452. ICRP Publication 101‏‎ (1 revision)
  453. Best available techniques‏‎ (1 revision)
  454. ICRP Publication 113‏‎ (1 revision)
  455. Bronchiolar region‏‎ (1 revision)
  456. Quasi-threshold dose‏‎ (1 revision)
  457. ICRP Publication 128‏‎ (1 revision)
  458. ICRP Publication 142‏‎ (1 revision)
  459. Compartment‏‎ (1 revision)
  460. Radon progeny‏‎ (1 revision)
  461. ICRP Publication 17‏‎ (1 revision)
  462. Count median diameter‏‎ (1 revision)
  463. Reference parameter value‏‎ (1 revision)
  464. ICRP Publication 30 (Part 1)‏‎ (1 revision)
  465. Deposition‏‎ (1 revision)
  466. ICRP Publication 90‏‎ (1 revision)
  467. ICRP Publication 39‏‎ (1 revision)
  468. Digital breast tomosynthesis‏‎ (1 revision)
  469. ICRP Publication 53‏‎ (1 revision)
  470. Size-specific dose estimate‏‎ (1 revision)
  471. ICRP Publication 68‏‎ (1 revision)
  472. Specific absorbed fraction‏‎ (1 revision)
  473. ICRP Publication 82‏‎ (1 revision)
  474. Surface contamination‏‎ (1 revision)
  475. Excess absolute risk‏‎ (1 revision)
  476. Exposure pathway‏‎ (1 revision)
  477. Translocation‏‎ (1 revision)
  478. Multistage carcinogenesis model‏‎ (1 revision)
  479. Functional subunits‏‎ (1 revision)
  480. Activity median aerodynamic diameter‏‎ (1 revision)
  481. Ground-level enhancement‏‎ (1 revision)
  482. Phantom‏‎ (1 revision)
  483. ICRP Publication 101a‏‎ (1 revision)
  484. ICRP Publication 114‏‎ (1 revision)
  485. ICRP Publication 129‏‎ (1 revision)
  486. ICRP Publication 143‏‎ (1 revision)
  487. Compartment (environmental)‏‎ (1 revision)
  488. Ras‏‎ (1 revision)
  489. ICRP Publication 18‏‎ (1 revision)
  490. Cross section‏‎ (1 revision)
  491. Reference phantom‏‎ (1 revision)
  492. ICRP Publication 30 (Part 2)‏‎ (1 revision)
  493. ICRP Publication 91‏‎ (1 revision)
  494. ICRP Publication 4‏‎ (1 revision)
  495. ICRP Publication 54‏‎ (1 revision)
  496. Slice‏‎ (1 revision)
  497. ICRP Publication 69‏‎ (1 revision)
  498. ICRP Publication 83‏‎ (1 revision)
  499. Threshold level‏‎ (1 revision)
  500. Organ at risk‏‎ (1 revision)

View (previous 500 | next 500) (20 | 50 | 100 | 250 | 500)